Genworth Financial (GNW) Stock Forecast and Price Target (2026)

Sell-side coverage follows trading volume and banking relationships, so smaller companies, recent listings, and names outside the major indices often carry little or none. That is the situation with GNW. It says nothing about the quality of the business, but it does mean there is no informed average to anchor to, and that any single target you find elsewhere is one analyst's model rather than a consensus.

Figures are approximate and tied to the asOf date; check live numbers before acting. Standard earnings multiples do little work here, because GAAP results consolidate all of Enact while charging the full drag of the long-term care closed block, and reported equity of ~$8.7 billion at June 30, 2026 includes the minority interest in Enact and swings with accumulated other comprehensive income. Most analysis of GNW is sum-of-the-parts instead: the market value of the Enact stake, less holding company debt and corporate costs, less whatever haircut the long-term care block deserves.

Not a published one. Analyst price targets run to about twelve months, occasionally two years, and the firms covering GNW do not put out a 2030 number. Anything presenting one is extrapolating a growth rate rather than reporting research, and a figure produced that way tells you about the assumption chosen, not about the company.

On the figures we hold as of October 2026, GNW trades at about 18.5 times trailing earnings and 8.6 times forward earnings. A forward multiple below the trailing one means the market expects earnings to grow, and the size of that gap is roughly how much growth is already in the price.

That is the more useful frame for a ten-year question. A share price is the market’s estimate of future cash flows discounted to today, so the multiple is already a statement about growth. The long-horizon question is whether Genworth Financial can deliver what is priced in, and what would have to change for that to break. Both are answerable from the drivers and risks below. A number for 2030 is not.

In short: the drivers cited most often are Enact cash flow and the holding company discount, The multi-year rate action plan on legacy long-term care, Capital returns against a discounted asset. The risk cited most often against it is the core risk is that the long-term care closed block turns out to cost more than reserved: morbidity, mortality, policyholder lapse behaviour and long-run interest rates all feed the reserve, and a deterioration can require capital that the holding company would rather deploy elsewhere.

Both sides are worked through properly, with the high and low targets used as the bull and bear anchors, on the GNW is it a buy page. This page deliberately stops at the numbers.